Not Yet RecruitingNot Applicable

Outcomes of Definitive Radiotherapy for Bladder Cancer

Egypt300 participantsStarted 2026-04-01

Plain-language summary

this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy Exclusion Criteria: * Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

overall survival, it is defined as time from initiation of treatment till death due to any cause or last date for follow up

Timeframe: one and two year

bladder intact events free survival , which is the time from initiation of radical ttt till occurrence of bladder recurrence

Timeframe: one and two year

disease free survival , it is time from starting radical ttt till occurrance of 1st recurrence or distant metastasis

Timeframe: one and two years

Trial details

NCT IDNCT07503795

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11-01

Contact for this trial

heba elsagheer

0201062162612 hebaelsagheer@yahoo.com

View on ClinicalTrials.gov More Bladder Cancer (BC) trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

overall survival, it is defined as time from initiation of treatment till death due to any cause or last date for follow up

Timeframe: one and two year

bladder intact events free survival , which is the time from initiation of radical ttt till occurrence of bladder recurrence

Timeframe: one and two year

disease free survival , it is time from starting radical ttt till occurrance of 1st recurrence or distant metastasis

Timeframe: one and two years